Observational Study
Copyright ©The Author(s) 2022.
World J Cardiol. Jul 26, 2022; 14(7): 411-426
Published online Jul 26, 2022. doi: 10.4330/wjc.v14.i7.411
Table 1 Characteristics of participants at baseline
Serum 25(OH)D concentrations
P value
< 20 ng/mL
20 to 29 ng/mL
≥ 30 ng/mL
No.
mean, %
(SE)
No.
mean, %
(SE)
No.
mean, %
(SE)
MetS, %< 0.001
No264064.7223070.8127679.3
Yes139435.3108929.246520.7
Age, yr403445.8(0.6)331944.7(0.6)174140.3(0.6)< 0.001
Waist circumference, cm403494.2(0.4)331992.2(0.3)174188.3(0.4)< 0.001
Body mass index, kg/m2403327.8(0.2)331826.5(0.1)173925.0(0.1)< 0.001
Systolic BP, mmHg4034123.4(0.6)3319122.0(0.6)1741119.0(0.6)<0.001
Diastolic BP, mmHg403474.7(0.3)331774.1(0.3)174172.9(0.4)< 0.001
Triglycerides, mg/dL4034138.9(4.1)3319136.4(2.6)1741126.5(3.8)< 0.001
HDL-C, mg/dL403451.0(0.5)331949.3(0.4)174151.5(0.6)< 0.001
Glucose, mg/dL4034100.7(0.7)331998.4(0.5)174194.7(0.4)< 0.001
Categorical variable, %
Sex, male, %156138.317851.997555.4< 0.001
Race/ethnicity, %< 0.001
NHW89455.1155779.7121392.0
NHB178825.85756.01391.9
Others135219.1118714.33896.1
Region< 0.001
Northeast49015.842920.630326.7
Midwest65118.970924.543428.1
South193340.3129933.268529.1
West96025.088221.631916.1
Education level0.001
< High school93013.181811.83558.2
High school197149.2153245.878846.1
> High school111337.794942.459245.6
Smoking0.07
Never256262.1223063.9113062.5
Former1935.51916.01054.0
Current127932.489830.250633.5
Alcohol consumption, yes170444.8159255.991063.7< 0.001
Exercise, yes0.13
More activity55914.147516.328718.4
About the same243358.3199856.2100552.7
Less activity104027.684127.544528.9
Health conditions
Hypertension, yes148936.5112929.656525.5< 0.001
Diabetes mellitus4659.33126.71053.3< 0.001
CVD2786.32525.31243.40.001
Table 2 Age-sex-adjusted mortality from heart disease, cerebrovascular disease, cardiovascular disease, and all-cause mortality
Observed number
Weighted mortalityrate per 10000 PY
P value
No. at risk
Case
Rate
(95%CI)
Heart Disease
25(OH)D, ng/mL
≥ 30174113011.7(8.2-16.6)Ref.
20-29331927213.2(10.3-16.9)0.43
< 20403429217.4(13.1-23.0)0.012
CBVD
25(OH)D, ng/mL
≥ 301741343.6(2.0-6.6)Ref.
20-293319833.6(2.5-5.1)0.97
< 204034884.5(2.5-7.9)0.53
CVD
25(OH)D, ng/mL
≥ 30174116415.3(11.4-20.5)Ref.
20-29331935516.6(13.3-20.7)0.56
< 20403438221.3(16.6-27.3)0.023
All-cause
25(OH)D, ng/mL
≥ 30174154575.9(64.9-88.8)Ref.
20-293319114187.5(79.4-96.3)0.066
< 2040341290103.9(93.2-115.8)< 0.001
MetS status
Heart Disease
MetS, no614632712.5(9.7-16.2)Ref.
MetS, yes294836916.7(12.9-21.7)0.002
CBVD
MetS, no6146973.2(2.2-4.7)Ref.
MetS, yes29481085.1(2.9-8.9)0.059
CVD
MetS, no614642415.9(13.0-19.5)Ref.
MetS, yes294847722.0(16.9-28.6)< 0.001
All-cause
MetS, no6146149082.5(75.3-90.5)Ref.
MetS, yes29481486102.4(91.0-115.3)< 0.001
Table 3 Hazard ratios of serum 25 hydroxyvitamin D concentration and metabolic syndrome for heart disease, cerebrovascular disease, cardiovascular disease, and all-cause mortality
Model 1
Model 2
HR
(95%CI)
P value
HR
(95%CI)
P value
Ref to 25(OH)D ≥ 30 ng/dL
25(OH)D for HD
20-291.13(0.82-1.55)0.451.13(0.83-1.52)0.43
< 201.54(1.14-2.08)0.0051.43(1.07-1.91)0.017
25(OH)D for CBVD
20-290.97(0.61-1.53)0.880.98(0.62-1.56)0.94
< 201.15(0.58-2.26)0.691.14(0.58-2.25)0.69
25(OH)D for CVD
20-291.09(0.82-1.46)0.541.10(0.82-1.46)0.52
< 201.44(1.09-1.91)0.0111.36(1.04-1.78)0.028
25(OH)D for all-cause mortality
20-291.16(0.99-1.35)0.061.16(0.99-1.36)0.07
< 201.38(1.16-1.64)0.0011.32(1.10-1.58)0.004
Ref to Non-MetS
MetS for HD1.31(1.09-1.58)0.0051.22(1.00-1.49)0.053
MetS for CBVD1.58(0.94-2.66)0.0831.60(0.96-2.65)0.069
MetS for CVD1.37(1.12-1.66)0.0021.29(1.05-1.59)0.017
MetS for all-cause mortality1.22(1.08-1.37)0.0021.20(1.05-1.36)0.008
Interaction of
25(OH)D x MetS on
HD0.91(0.72-1.17)0.460.91(0.72-1.15)0.41
CBVD0.80(0.39-1.66)0.540.79(0.38-1.62)0.50
CVD0.89(0.71-1.12)0.310.88(0.70-1.11)0.28
All-cause0.98(0.84-1.14)0.780.96(0.82-1.13)0.63
Table 4 Top 10 important predicators for classifying serum 25 Hydroxyvitamin D levels in the total and sex-specific samples
S1: In both sex
S2: In males
S3: In females
S4: In both sex
S5: In males
S6: In females
≥ 20 vs < 20
≥ 20 vs < 20
≥ 20 vs < 20
≥ 30 vs < 30
≥ 30 vs < 30
≥ 30 vs < 30
RankPredictorMDGPredictorMDGPredictorMDGPredictorMDGPredictorMDGPredictorMDG
1Race519.5Race229.7Race267.7Race200.0Race95.2Race103.9
2Folate90.4RBP19.6Folate101.3Age97.5WC34.0Age79.4
3Sex57.3Age14.8Age77.5Folate65.1BMI29.0GFR50.6
4Region34.3Glucose14.2GFR73.7GFR54.8AGE28.9Folate49.6
5RBP34.0GFR13.1RBP50.7BMI48.8Region24.8RBP34.1
6Poverty33.3Poverty12.8Poverty50.1WC42.2GFR22.7WC32.0
7Edu30.3Region11.9WC22.9Poverty41.4Insulin18.9SBP26.9
8GFR29.6WC11.1VEP21.1RBP39.8C1P18.8BMI23.2
9UAP27.7Folate10.9SBP16.1Glucose22.0RBP18.6VEP22.0
10Alcoh21.6Edu9.8A1C14.6DairyHEI20.8Poverty17.4Poverty18.8
Accuracy,%71.170.868.081.579.381.8
Precision, %68.468.268.283.082.485.6
Recall,%63.047.568.597.093.594.0
F1 score, %65.656.068.389.587.689.6